Artwork

Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

174: Quest's vision for genomics at scale

34:26
 
Share
 

Manage episode 373569885 series 2762568
Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In recent years, there has been a major influx of new genetic tests that have hit the market. While these tests promise to revolutionize diagnostics and treatment decision-making, the industry needs to overcome a variety of reimbursement and logistical barriers to achieve any goals for genomics at scale.

In this episode, guest host and Advisory Board expert partner Devin Airey invites Mark Gardner, the SVP of Genomic Medicine and Oncology at Quest Diagnostics, and Dan Edelstein, President and CEO of Haystack Oncology, to discuss their vision for genomics at scale. Throughout the conversation, they discuss increased attention from providers and purchasers, how to integrate new genomics technology into patient care, and how to address opportunities and concerns in the market.

Links:



[Webinar] Consumer insights decision makers should lead with in 2023 (August 24 | 3-4pm ET)

  continue reading

227 episodes

Artwork

174: Quest's vision for genomics at scale

Radio Advisory

16,366 subscribers

published

iconShare
 
Manage episode 373569885 series 2762568
Content provided by Advisory Board. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Advisory Board or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In recent years, there has been a major influx of new genetic tests that have hit the market. While these tests promise to revolutionize diagnostics and treatment decision-making, the industry needs to overcome a variety of reimbursement and logistical barriers to achieve any goals for genomics at scale.

In this episode, guest host and Advisory Board expert partner Devin Airey invites Mark Gardner, the SVP of Genomic Medicine and Oncology at Quest Diagnostics, and Dan Edelstein, President and CEO of Haystack Oncology, to discuss their vision for genomics at scale. Throughout the conversation, they discuss increased attention from providers and purchasers, how to integrate new genomics technology into patient care, and how to address opportunities and concerns in the market.

Links:



[Webinar] Consumer insights decision makers should lead with in 2023 (August 24 | 3-4pm ET)

  continue reading

227 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide